DK2089030T3 - Middel til profylakse eller behandling af alkoholafhængighed eller lægemiddelafhængighed - Google Patents

Middel til profylakse eller behandling af alkoholafhængighed eller lægemiddelafhængighed

Info

Publication number
DK2089030T3
DK2089030T3 DK07830236.1T DK07830236T DK2089030T3 DK 2089030 T3 DK2089030 T3 DK 2089030T3 DK 07830236 T DK07830236 T DK 07830236T DK 2089030 T3 DK2089030 T3 DK 2089030T3
Authority
DK
Denmark
Prior art keywords
drug
dependence
prophylaxis
treatment
alcohol
Prior art date
Application number
DK07830236.1T
Other languages
English (en)
Inventor
Roberto Ciccocioppo
Maurizio Massi
Koji Teshima
Original Assignee
Mitsubishi Tanabe Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Tanabe Pharma Corp filed Critical Mitsubishi Tanabe Pharma Corp
Application granted granted Critical
Publication of DK2089030T3 publication Critical patent/DK2089030T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Addiction (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK07830236.1T 2006-10-16 2007-10-16 Middel til profylakse eller behandling af alkoholafhængighed eller lægemiddelafhængighed DK2089030T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06122336 2006-10-16
PCT/JP2007/070502 WO2008050698A2 (en) 2006-10-16 2007-10-16 Agent for prophylaxis or treatment of alcohol dependence or drug dependence

Publications (1)

Publication Number Publication Date
DK2089030T3 true DK2089030T3 (da) 2011-12-05

Family

ID=37806857

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07830236.1T DK2089030T3 (da) 2006-10-16 2007-10-16 Middel til profylakse eller behandling af alkoholafhængighed eller lægemiddelafhængighed

Country Status (16)

Country Link
US (1) US8207201B2 (da)
EP (1) EP2089030B1 (da)
JP (1) JP5089687B2 (da)
KR (1) KR101187509B1 (da)
CN (1) CN101600433B (da)
AT (1) ATE524180T1 (da)
AU (1) AU2007310209B2 (da)
BR (1) BRPI0717161A2 (da)
CA (1) CA2666630C (da)
DK (1) DK2089030T3 (da)
ES (1) ES2370276T3 (da)
MX (1) MX2009004012A (da)
PL (1) PL2089030T3 (da)
PT (1) PT2089030E (da)
RU (1) RU2419433C2 (da)
WO (1) WO2008050698A2 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201016675A (en) * 2008-09-16 2010-05-01 Mitsubishi Tanabe Pharma Corp Crystalline benzoimidazole compound and salt thereof
TWI582096B (zh) * 2011-12-06 2017-05-11 美國禮來大藥廠 用於酒精依賴及濫用處理之４',５'－二氫螺［哌啶－４,７'－噻吩并[２，３－c]哌喃］化合物
CA3224323A1 (en) * 2021-07-14 2023-01-19 Jian Wang Piperidine derivative, and pharmaceutical composition thereof, preparation method therefor, and use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL342046A1 (en) 1998-01-19 2001-05-21 Pfizer 4-(2-keto-1-benzimidazolinyl)piperidine compounds as agonists of orl1 receptor
US7566728B2 (en) 2002-03-29 2009-07-28 Mitsubishi Tanabe Pharma Corporation Remedy for sleep disturbance
SA04250305B1 (ar) 2003-09-25 2008-06-02 سولفاي فارماسوتيكالز بي . في مشتقات بنزيميدازولون cenzimidazolone وكينازولينون quinazolinone كمساعادات على مستقبلات ORL1 البشرية
WO2006025267A1 (ja) * 2004-08-31 2006-03-09 Mitsubishi Pharma Corporation Per2タンパク質レベルの低下を作用機序とする睡眠障害治療薬
TW201016675A (en) * 2008-09-16 2010-05-01 Mitsubishi Tanabe Pharma Corp Crystalline benzoimidazole compound and salt thereof

Also Published As

Publication number Publication date
KR101187509B1 (ko) 2012-10-02
CA2666630A1 (en) 2008-05-02
ES2370276T3 (es) 2011-12-14
KR20090069336A (ko) 2009-06-30
PL2089030T3 (pl) 2012-02-29
EP2089030B1 (en) 2011-09-14
RU2419433C2 (ru) 2011-05-27
WO2008050698A3 (en) 2008-10-02
ATE524180T1 (de) 2011-09-15
PT2089030E (pt) 2011-09-27
JP5089687B2 (ja) 2012-12-05
RU2009118439A (ru) 2010-11-27
BRPI0717161A2 (pt) 2013-10-15
CN101600433B (zh) 2012-09-26
CN101600433A (zh) 2009-12-09
EP2089030A2 (en) 2009-08-19
AU2007310209B2 (en) 2011-11-17
US8207201B2 (en) 2012-06-26
JP2010505746A (ja) 2010-02-25
AU2007310209A1 (en) 2008-05-02
WO2008050698A2 (en) 2008-05-02
MX2009004012A (es) 2009-04-27
US20100069382A1 (en) 2010-03-18
CA2666630C (en) 2012-01-24

Similar Documents

Publication Publication Date Title
MX2009008540A (es) Inhibidores de virus de hepatitis c macrociclicos sustituidos con pirimidina.
NO20090628L (no) Pyridizinon derivativater
CL2008000946A1 (es) Compuestos derivados de pirrolopirimidina, inhibidores de cianasa jak3; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de rechazo de transplantes, enfermedades autoinmun
HK1203497A1 (en) Non-systemic tgr5 agonists
MX2009008541A (es) Fenilcarbamatos macrociclicos que inhiben el virus de hepatitis c.
EA200900135A1 (ru) Производные пиразола в качестве ингибиторов цитохрома р450
DK2069374T4 (da) Krystallinske solvater af (1s)-1,5-anhydro-1-c-(3-((phenyl) methyl)phenyl)-d-glucitolderivater med alkoholer som sglt2-inhibitorer til behandling af diabetes
UY29562A1 (es) Compuestos heterocíclicos de amino benzoilo, composiciones farmacéuticas que los contienen, procedimientos de preparación y aplicaciones
NO20084659L (no) Ko-krystall av C-glucosidderivat og L-prolin
EA200970532A1 (ru) Фумаратная соль (альфа s, бета r)-6-бром-альфа-[2-(диметиламино)этил]-2-метокси-альфа-1-нафталенил-бета-фенил-3-хинолинэтанола
DK1934174T3 (da) Azetidiner som MEK inhibitorer til behandling af proliferative sygdomme
ATE430747T1 (de) 2-pyrimidinyl-pyrazolopyridin-erbb- kinaseinhibitoren
DK1807072T3 (da) Cycloalkyllactamderivater som inhibitorer af 11-beta-hydroxysteroid-dehydrogenase 1
CL2008003798A1 (es) Compuestos derivados de heterobiciclos aromaticos sustituidos, inhibidores de pi3 quinasa; composicion farmaceutica; utiles en el tratamiento de cancer, melanomas, glioblastomas, entre otras enfermedades.
EA201170680A1 (ru) Ингибиторы акт и p70 s6-киназы
EA201270590A1 (ru) Ингибиторы акт
TN2012000347A1 (en) 4-[-2-[[5-methyl-1-(2-naphtalenyl)-1h-pyrazol-3-yl]oxy]ethyl]morpholine hydrochloride polymorphs and solvates
TW200806291A (en) Pharmaceutical formulations
DE602006011752D1 (de) Als antikoagulationsmittel geeignete phenylglycinamid- und pyridylglycinamidderivate
EA201071395A1 (ru) Ингибитор толерантности к анальгетику
CL2007000595A1 (es) Compuestos derivados de piperidina; composicion farmaceutica y uso para el tratamiento y/o profilaxis de enfermedades seleccionadas entre hipertension, insuficiencia cardiaca congestiva e insuficiencia renal entre otras.
EA200900631A1 (ru) Замещённые пиразолы и триазолы, как ингибиторы кбв (кинезин-белок веретена)
DK1937639T3 (da) Pyridinaminosulfonyl-substituerede benzamider som inhibitorer af cytochrom P450 3A4 (CYP3A4)
NI200700189A (es) Ciclopropil -(2,3-dimetilbencil)amidos del ácido 7-{4-[2-(2,6-dicloro-4-metilfenoxi)- etoxi]fenil}-3,9- diazabiciclo [3.3.1]non-6-en-6-carboxílico como inhibidores de renina para el tratamiento de la hipertensión.
GEP20135805B (en) 1-(ARYLSULFONYL)-4-(PIPERAZIN-1-YL)-1H-BENZIMIDAZOLES AS δ-HYDROXYTRYPTAMINE-6 LIGANDS